Kairos Pharma, Ltd.
KAPA
$0.96
$0.05265.80%
AMEX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3,149.49% | -90.95% | -88.80% | -78.72% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -41.18% | -34.62% | 11.76% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3,987.93% | -85.27% | -84.22% | -76.89% | -- |
|
|
|||||
| Total Current Assets | 3,987.93% | -85.27% | -84.22% | -76.89% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -37.91% | -34.63% | -31.87% | -29.52% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 167.44% | 342.64% | 745.61% | -- |
| Total Assets | 427.85% | 5.32% | -3.28% | -6.85% | -- |
|
|
|||||
| Total Accounts Payable | -30.61% | 50.08% | 56.40% | 47.39% | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 3,450.00% | 2,550.00% | 0.00% | 0.00% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -24.31% | 55.24% | 56.27% | 47.27% | -- |
|
|
|||||
| Total Current Liabilities | -24.31% | 55.24% | 56.27% | 47.27% | -- |
| Long-Term Debt | -- | 12.46% | 10.98% | 9.62% | -- |
| Short-term Debt | 3,450.00% | 2,550.00% | 0.00% | 0.00% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -40.73% | 45.10% | 44.76% | 37.38% | -- |
|
|
|||||
| Common Stock & APIC | 246.69% | 28.35% | 28.35% | 28.35% | -- |
| Retained Earnings | -53.81% | -41.95% | -43.75% | -41.18% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 277.90% | -70.02% | -81.21% | -76.25% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 277.90% | -70.02% | -81.21% | -76.25% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 277.90% | -70.02% | -81.21% | -76.25% | -- |
|
|
|||||